Evidence map›Paper›PMID 31120050›Full record

ArticleFaraday discussions2019

Deciphering complex metabolite mixtures by unsupervised and supervised substructure discovery and semi-automated annotation from MS/MS spectra.

Simon Rogers, Cher Wei Ong, Joe Wandy, Madeleine Ernst, Lars Ridder, Justin J J van der Hooft

Abstract read
In one paragraph

Article in Faraday discussions, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Metabolomic Profiling ofMolecules (Basel, Switzerland) · 2025
    Article
  9. Review
  10. Article
  11. Charting the Cannabis plant chemical space with computational metabolomics.Metabolomics : Official journal of the Metabolomic Society · 2024
    Article
  12. Article
  13. Article
  14. Effects of Long-Term Storage on the Biobanked Neonatal Dried Blood Spot Metabolome.Journal of the American Society for Mass Spectrometry · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Discovering New Natural Products Using Metabolomics-Based Approaches.Advances in experimental medicine and biology · 2023
    Article
  19. Article
  20. A Relook into the Flavonoid Chemical Space ofJournal of analytical methods in chemistry · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Simon RogersSchool of Computing Science, University of Glasgow, Glasgow, UK.ORCID 0000-0003-3578-4477
Cher Wei OngSchool of Computing Science, University of Glasgow, Glasgow, UK.
Joe WandyGlasgow Polyomics, University of Glasgow, Glasgow, UK.ORCID 0000-0002-3068-4664
Madeleine ErnstCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, San Diego, California, USA.ORCID 0000-0001-9530-3837
Lars RidderNetherlands eScience Center, Amsterdam, The Netherlands.ORCID 0000-0002-7635-9533
Justin J J van der HooftBioinformatics Group, Wageningen University, Wageningen, The Netherlands. justin.vanderhooft@wur.nl.ORCID 0000-0002-9340-5511

Funding

Biotechnology and Biological Sciences Research Council BB/R022054/1
6 · The paper itself

Abstract

Complex metabolite mixtures are challenging to unravel. Mass spectrometry (MS) is a widely used and sensitive technique for obtaining structural information of complex mixtures. However, just knowing the molecular masses of the mixture's constituents is almost always insufficient for confident assignment of the associated chemical structures. Structural information can be augmented through MS fragmentation experiments whereby detected metabolites are fragmented, giving rise to MS/MS spectra. However, how can we maximize the structural information we gain from fragmentation spectra? We recently proposed a substructure-based strategy to enhance metabolite annotation for complex mixtures by considering metabolites as the sum of (bio)chemically relevant moieties that we can detect through mass spectrometry fragmentation approaches. Our MS2LDA tool allows us to discover - unsupervised - groups of mass fragments and/or neutral losses, termed Mass2Motifs, that often correspond to substructures. After manual annotation, these Mass2Motifs can be used in subsequent MS2LDA analyses of new datasets, thereby providing structural annotations for many molecules that are not present in spectral databases. Here, we describe how additional strategies, taking advantage of (i) combinatorial in silico matching of experimental mass features to substructures of candidate molecules, and (ii) automated machine learning classification of molecules, can facilitate semi-automated annotation of substructures. We show how our approach accelerates the Mass2Motif annotation process and therefore broadens the chemical space spanned by characterized motifs. Our machine learning model used to classify fragmentation spectra learns the relationships between fragment spectra and chemical features. Classification prediction on these features can be aggregated for all molecules that contribute to a particular Mass2Motif and guide Mass2Motif annotations. To make annotated Mass2Motifs available to the community, we also present MotifDB: an open database of Mass2Motifs that can be browsed and accessed programmatically through an Application Programming Interface (API). MotifDB is integrated within ms2lda.org, allowing users to efficiently search for characterized motifs in their own experiments. We expect that with an increasing number of Mass2Motif annotations available through a growing database, we can more quickly gain insight into the constituents of complex mixtures. This will allow prioritization towards novel or unexpected chemistries and faster recognition of known biochemical building blocks.

Indexed as

AutomationSupervised Machine LearningUnsupervised Machine LearningComplex MixturesDatabases, FactualTandem Mass SpectrometryComplex Mixtures

Identifiers

PMID31120050
PMCPMC13250438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.